Physician profile
John Cameron
NPI 1265097596
$15,013.64
in general payments reported to CMS, 2019-2025
36 companies · $671 in 2025
The $671 reported for 2025 was more than what a typical Foot & Ankle Surgery provider received nationally (typical 2025 total: $424).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,428 · 2020: $61.84 · 2021: $684 · 2022: $2,425 · 2023: $2,020 · 2024: $7,724 · 2025: $671.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $4,800 · Food and Beverage: $3,797 · Travel and Lodging: $1,818.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $4,800.00 |
| Food and Beverage | $3,796.65 |
| Travel and Lodging | $1,817.87 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Amgen INC. | $6,472.65 | 2024-2025 | Krystexxa |
| Mid-Atlantic Surgical Systems, LLC | $2,398.58 | 2019-2022 | |
| Aroa Biosurgery Incorporated | $1,155.09 | 2023-2025 | |
| Paragon 28, INC. | $974.90 | 2021-2023 | Portfolio, Precision Guide Lapidus |
| Integra Lifesciences Corporation | $879.93 | 2019-2025 | Integra, Primatrix, Integra Dermal Regeneration Template |
| Organogenesis INC. | $363.71 | 2021-2025 | Apligraf, Apligraf, Puraply |
| Paratek Pharmaceuticals, INC. | $350.60 | 2022-2025 | Nuzyra |
| Stryker Corporation | $296.81 | 2022-2023 | N/A, Prophecy, Citrefix |
| Acumed LLC | $272.17 | 2022 | |
| Medtronic, INC. | $211.59 | 2024-2025 | Intellis Adaptivestim |
| Horizon Therapeutics Plc | $201.74 | 2022-2023 | Krystexxa |
| Kerecis Limited | $198.66 | 2019-2021 | |
| Djo, LLC | $169.11 | 2024-2025 | Cmf |
| Abbvie INC. | $125.00 | 2022 | |
| Biotissue Holdings INC. | $114.71 | 2021 |
Show all 36 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Acera Surgical, INC. | $94.37 | 2024-2025 | Restrata Wound Matrix |
| Acell, INC. | $79.15 | 2019 | |
| Boston Scientific Corporation | $70.93 | 2024 | Varithena Administration Pack |
| Zimmer Biomet Holdings, INC. | $68.02 | 2019 | |
| Treace Medical Concepts, INC. | $60.70 | 2025 | |
| Pacira Pharmaceuticals Incorporated | $55.21 | 2025 | |
| Smith+Nephew, INC. | $46.00 | 2023-2024 | Collagenase Santyl, Acticoat 4" X 4" |
| Polynovo North America LLC | $42.43 | 2024 | Novosorb Btm |
| Melinta Therapeutics, LLC | $39.13 | 2023 | Kimyrsa, Orbactiv, Vabomere |
| Kci USA, INC. | $37.78 | 2022-2023 | Activ.A.C., Snap, Promogran Prisma |
| Solventum Corporation | $33.28 | 2024-2025 | Activ.A.C., Apc Flash-Free Clarity Advanced, Adaptic |
| Mimedx Group, INC. | $32.92 | 2025 | |
| Tactile Systems Technology INC | $31.66 | 2022 | |
| Bard Peripheral Vascular, INC. | $22.81 | 2024 | Venclose Maven Catheter |
| Reprise Biomedical, INC. | $20.46 | 2023 | Miro3d |
| Becton, Dickinson and Company | $18.07 | 2024 | Venclose Maven Catheter |
| Ortho Dermatologics, A Division of Bausch Health US, LLC | $17.74 | 2025 | Jublia |
| Nevro Corp. | $15.60 | 2021 | |
| Osteomed LLC | $15.08 | 2020 | |
| Orthofix Medical, INC. | $13.64 | 2025 | Physio-Stim |
| Convatec INC. | $13.41 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw John Cameron listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.